Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Monogastric Digestion?01:50

What is Monogastric Digestion?

73.6K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
73.6K
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

864
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
864

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein digestion using a cysteine-specific backbone cleavage reagent.

RSC chemical biology·2026
Same author

An autopsy-based study on child mortality under six in Taiwan: Forensic autopsy findings and the complexities of causal determination.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same author

Integration of multi-omics for precision therapy in breast cancer.

Drug discovery today·2026
Same author

Curcumin Combined with Flaxseed Oil Modulates Lipid Metabolism in Hamsters Fed a High-Fat, High-Cholesterol Diet: Insights from Lipidomics.

Nutrients·2026
Same author

Gut microbiome features associated with vancomycin-resistant Enterococcus acquisition in intensive care unit patients.

Annals of clinical microbiology and antimicrobials·2026
Same author

Molecular Imaging in Primary Aldosteronism Subtyping: A Promising Complement but Not Yet a Replacement for Adrenal Venous Sampling.

Journal of the American Heart Association·2026

Related Experiment Video

Updated: Nov 8, 2025

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

4.8K

Mining Gut Microbiota From Bariatric Surgery for MAFLD.

Wei-Kai Wu1,2, Yi-Hsun Chen3, Po-Chu Lee4

  • 1Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.

Frontiers in Endocrinology
|April 26, 2021
PubMed
Summary

Bariatric surgery improves metabolic dysfunction associated fatty liver disease (MAFLD) by altering gut microbiota. Further research into these gut-liver axis mechanisms could reveal new therapeutic targets for MAFLD.

Keywords:
MAFLDbariatric surgerygut microbiotagut–liver axishuman microbiota associated micemulti-omicsportal vein

More Related Videos

A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model
08:14

A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model

Published on: February 28, 2018

9.0K
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.9K

Related Experiment Videos

Last Updated: Nov 8, 2025

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

4.8K
A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model
08:14

A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model

Published on: February 28, 2018

9.0K
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.9K

Area of Science:

  • Gastroenterology and Hepatology
  • Microbiome Research
  • Metabolic Disease Research

Background:

  • Metabolic dysfunction associated fatty liver disease (MAFLD) can progress to severe liver conditions like steatohepatitis, fibrosis, and cancer.
  • Currently, no FDA-approved medications exist specifically for MAFLD treatment.
  • Bariatric surgery (BS) shows promise in improving MAFLD markers but is too invasive for routine treatment.

Purpose of the Study:

  • To review current literature on the metabolic benefits of bariatric surgery (BS) in treating MAFLD.
  • To focus on the role of gut microbiota and its metabolites in mediating BS-induced improvements in MAFLD.
  • To explore the gut-liver axis as a potential area for novel MAFLD therapeutic targets.

Main Methods:

  • Literature review focusing on studies investigating BS, MAFLD, and gut microbiota.
  • Discussion of proposed mechanisms involving gut microbiota alterations, short-chain fatty acids, and bile acids.
  • Presentation and discussion of translational research tools like rodent BS models, multiomics, and human microbiota-associated (HMA) mice.

Main Results:

  • Bariatric surgery (BS) is associated with improved glucose metabolism, insulin resistance, steatohepatitis, and liver fibrosis in MAFLD patients.
  • Alterations in gut microbiota composition and metabolites (e.g., bile acids) are suggested mechanisms for BS benefits.
  • The gut-liver axis is highlighted as a critical pathway influencing MAFLD progression and response to BS.

Conclusions:

  • The gut microbiota plays a significant role in the metabolic improvements observed after bariatric surgery for MAFLD.
  • Understanding microbiota-mediated pathways offers potential for developing targeted MAFLD therapies.
  • Modern translational tools are crucial for uncovering these microbiota-related therapeutic targets.